UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
American journal of respiratory and critical care medicine, ISSN 1073-449X, 03/2016, Volume 193, Issue 5, pp. 504 - 515
Healthy controls | Cystic fibrosis | Microbiota | Nasopharynx | Longitudinal | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Carrier State - epidemiology | Streptococcus mitis - genetics | Prospective Studies | Humans | Corynebacterium Infections - epidemiology | Carrier State - microbiology | Haemophilus Infections - epidemiology | Infant | Male | Corynebacterium Infections - microbiology | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Female | Staphylococcal Infections - microbiology | Nasopharynx - microbiology | Real-Time Polymerase Chain Reaction | Burkholderia Infections - microbiology | Haemophilus Infections - drug therapy | Infant, Newborn | Staphylococcus aureus - genetics | Moraxellaceae Infections - epidemiology | Streptococcal Infections - microbiology | Burkholderia - genetics | Staphylococcal Infections - drug therapy | Burkholderia Infections - epidemiology | Cystic Fibrosis - microbiology | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae - genetics | Moraxellaceae Infections - microbiology | Streptococcal Infections - epidemiology | Haemophilus influenzae - genetics | Corynebacterium - genetics | Cystic Fibrosis - epidemiology | Moraxellaceae Infections - drug therapy | DNA, Bacterial - genetics | Staphylococcal Infections - epidemiology | Corynebacterium Infections - drug therapy | Microbiota - genetics | Burkholderia Infections - drug therapy | Haemophilus Infections - microbiology | RNA, Ribosomal, 16S - genetics | Streptococcal Infections - drug therapy | Moraxella - genetics | Cohort Studies | Enterobacteriaceae Infections - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 3/2012, Volume 54, Issue 6, pp. 743 - 751
Pediatrics | Microbial colonization | Infectious diseases | Disease transmission | Methicillin resistant staphylococcus aureus | P values | Infections | Soft tissue infections | ARTICLES AND COMMENTARIES | Decolonization | Staphylococcus aureus | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Medical sciences | Bacterial diseases | Human bacterial diseases | Soft Tissue Infections - prevention & control | Humans | Child, Preschool | Mupirocin - administration & dosage | Infant | Male | Staphylococcal Skin Infections - prevention & control | Baths | Young Adult | Staphylococcal Skin Infections - drug therapy | Community-Acquired Infections - drug therapy | Adult | Female | Soft Tissue Infections - drug therapy | Chlorhexidine - administration & dosage | Groin - microbiology | Child | Patient Education as Topic | Soft Tissue Infections - therapy | Staphylococcal Skin Infections - therapy | Combined Modality Therapy | Family Characteristics | Anti-Infective Agents, Local - administration & dosage | Axilla - microbiology | Adolescent | Carrier State - drug therapy | Intention to Treat Analysis | Nose - microbiology | Patient Compliance | Anti-Bacterial Agents - administration & dosage | Control | Research | Comparative analysis | Staphylococcus aureus infections | Infection control | Comparative studies | Clinical trials | Staphylococcus infections | Households | Disease control | Infection | Education | Skin | Children | Colonization | Hygiene | Index Medicus | and Commentaries
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 1/2013, Volume 56, Issue 2, pp. 182 - 194
Joint prostheses | Debridement | Symptomatology | Health outcomes | Infectious diseases | Antibiotics | Antimicrobials | Infections | ARTICLES AND COMMENTARIES | Staphylococcus aureus | Prosthetics | antibiotics and implant retention (DAIR) | rifampin | MRSA | prosthetic joint infection | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Miscellaneous. Osteoarticular involvement in other diseases | Bacterial diseases | Human bacterial diseases | Diseases of the osteoarticular system | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Medical sciences | Arthritis, Infectious - diagnosis | Prognosis | Arthritis, Infectious - mortality | Humans | Methicillin-Resistant Staphylococcus aureus - drug effects | Middle Aged | Male | Treatment Outcome | Prosthesis-Related Infections - therapy | Staphylococcal Infections - therapy | Anti-Bacterial Agents - therapeutic use | Staphylococcal Infections - mortality | Staphylococcal Infections - diagnosis | Treatment Failure | Aged, 80 and over | Adult | Female | Rifampin - therapeutic use | Aged | Prosthesis-Related Infections - diagnosis | Retrospective Studies | Staphylococcus aureus - drug effects | Arthritis, Infectious - therapy | Prosthesis-Related Infections - mortality | Care and treatment | Usage | Implants, Artificial | Prosthesis | Staphylococcal infections | Research | Surgical wound infections | Health aspects | Staphylococcus infections | Joint surgery | Disease management | Transplants & implants | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 9/2014, Volume 59, Issue 6, pp. 851 - 857
ARTICLES AND COMMENTARIES | Streptococcus pyogenes | Polyspecific intravenous immunoglobulin | Clindamycin | Necrotizing fasciitis | Streptococcal toxic shock syndrome | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Infectious diseases | Bacterial diseases | Human bacterial diseases | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Intensive care medicine | Emergency and intensive care: infection, septic shock | Medical sciences | Prognosis | Prospective Studies | Age Factors | Humans | Middle Aged | Male | Shock, Septic - diagnosis | Shock, Septic - therapy | Streptococcal Infections - mortality | Streptococcus pyogenes - genetics | Anti-Bacterial Agents - therapeutic use | Aged, 80 and over | Adult | Female | Streptococcus pyogenes - classification | Odds Ratio | Streptococcal Infections - microbiology | Streptococcal Infections - therapy | Comorbidity | Treatment Outcome | Shock, Septic - mortality | Clindamycin - therapeutic use | Streptococcal Infections - diagnosis | Immunoglobulins, Intravenous - therapeutic use | Aged | Immunoglobulins | Care and treatment | Mortality | Physiological aspects | Streptococcal infections | Research | Risk factors | Regression analysis | Comparative analysis | Streptococcus infections | Index Medicus | Medicin och hälsovetenskap
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 10/2015, Volume 132, Issue 15, pp. 1435 - 1486
anti-infective agents | infection | endocarditis | echocardiography | AHA Scientific Statements | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Humans | Candidiasis - diagnosis | Endocarditis - microbiology | Endocarditis - diagnosis | Prosthesis-Related Infections - microbiology | Rheumatic Heart Disease - complications | Adult | Prosthesis-Related Infections - diagnosis | Endocarditis - complications | Staphylococcal Infections - drug therapy | Endocarditis - therapy | Risk Factors | Bacteremia - complications | Heart Valve Prosthesis - adverse effects | Anti-Infective Agents - therapeutic use | Anticoagulants - therapeutic use | Diagnostic Techniques, Cardiovascular - standards | Bacteremia - diagnosis | Prosthesis-Related Infections - therapy | Staphylococcal Infections - diagnosis | Streptococcal Infections - diagnosis | Heart Valve Prosthesis - microbiology | Anti-Infective Agents - pharmacokinetics | Candidiasis - therapy | Streptococcal Infections - drug therapy | Medical personnel | Care and treatment | Infective endocarditis | Practice | Anti-infective agents | Adults | Dosage and administration | Diagnosis | Health aspects | Index Medicus | Abridged Index Medicus
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 12/2010, Volume 16, Issue 12, pp. 1789 - 1795
treatment | Acute infection | antibiotic therapy | prosthetic joint infections | haematogenous infection | Haematogenous infection | Treatment | Prosthetic joint infections | Antibiotic therapy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Miscellaneous. Osteoarticular involvement in other diseases | Infectious diseases | Pharmacology. Drug treatments | Diseases of the osteoarticular system | Biological and medical sciences | Medical sciences | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Arthroplasty, Replacement - adverse effects | Staphylococcal Infections - drug therapy | Prospective Studies | Humans | Risk Factors | Staphylococcal Infections - surgery | Gram-Negative Bacterial Infections - drug therapy | Treatment Outcome | Patient Care Management | Prosthesis-Related Infections - drug therapy | Prosthesis-Related Infections - therapy | Anti-Bacterial Agents - therapeutic use | Prosthesis-Related Infections - surgery | Streptococcal Infections - surgery | Case Management | Prosthesis-Related Infections - microbiology | Bacteremia - therapy | Treatment Failure | Female | Gram-Negative Bacterial Infections - surgery | Streptococcal Infections - drug therapy | Aged | Drug Therapy, Combination | Implants, Artificial | Prosthesis | Analysis | Staphylococcus aureus infections | Cross infection | Joint replacement | Nosocomial infections | Health aspects | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 375, Issue 9725, pp. 1557 - 1568
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Medical sciences | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Community-Acquired Infections - diagnosis | Community-Acquired Infections - therapy | Leukocidins - genetics | Staphylococcal Infections - genetics | Community-Acquired Infections - epidemiology | Humans | Staphylococcal Infections - therapy | Drainage | Anti-Bacterial Agents - therapeutic use | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Staphylococcal Infections - diagnosis | Staphylococcal Infections - epidemiology | Exotoxins - genetics | Nasal Cavity - microbiology | Bacterial Toxins - genetics | Hospitals | Cross infection | Nosocomial infections | Virulence (Microbiology) | Health aspects | Staphylococcus aureus | Risk factors | Drug abuse | Substance abuse treatment | Bacterial infections | Antibiotics | Pathogenesis | Natural products | Staphylococcus infections | Skin | Index Medicus | Abridged Index Medicus | Drug resistance
Journal Article